Evidence map›Paper›PMID 26545203›Full record

Trial reportJournal of pediatric gastroenterology and nutrition2016

Probiotic Administration in Infants With Gastroschisis: A Pilot Randomized Placebo-Controlled Trial.

Weston T Powell, Robyn A Borghese, Karen M Kalanetra, Majid Mirmiran, David A Mills, Mark A Underwood

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of pediatric gastroenterology and nutrition, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Impact ofNutrients · 2024
    Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Nutrients · 2020
    Review
  16. Article
  17. Review
  18. Efficacy ofGut microbes
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Weston T Powell *Department of Pediatrics, University of California Davis, Sacramento, CA.
Robyn A Borghese *Department of Pediatrics, University of California Davis, Sacramento, CA.
Karen M KalanetraDepartment of Food Science and Technology, University of California Davis, Davis, CA.
Majid MirmiranDepartment of Pediatrics, University of California Davis, Sacramento, CA.
David A MillsDepartment of Food Science and Technology, University of California Davis, Davis, CA.
Mark A UnderwoodDepartment of Pediatrics, University of California Davis, Sacramento, CA.

Funding

UC Davis Clinical and Translational Science CenterUL1TR000002 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERGLUND, LARS F · 2012 to 2015
$12.2M
Necrotizing Enterocolitis: Prevention and PredictionR01HD059127 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LEBRILLA, CARLITO B, MILLS, DAVID ANDREW · 2008 to 2012
$3.1M
NCATS NIH HHS UL1 TR000002NICHD NIH HHS R01 HD059127
6 · The paper itself

Abstract

objectivesInfants with gastroschisis often require long periods of gastric suctioning and hospitalization. The impact of these interventions on the intestinal microbiota and attempts to alter the microbial community have not been studied. We sought to determine how the intestinal microbiota is influenced by the current treatment of gastroschisis and whether alteration of the intestinal microbiota with a probiotic microbe will influence length of hospitalization.

methodsWe performed a randomized, placebo-controlled pilot study of administration of probiotic Bifidobacterium longum subsp. infantis in 24 infants with gastroschisis. The primary outcome was changes in the fecal microbiota, and the secondary outcome was length of hospital stay.

resultsAdministration of the probiotic or placebo was well tolerated, even during the period of gastric suctioning. The overall microbial communities were not significantly different between groups, although analysis of the final specimens by family demonstrated higher Bifidobacteriaceae, lower Clostridiaceae, and trends toward lower Enterobacteriaceae, Enterococcaceae, Staphylococcaceae, and Streptococcaceae in the probiotic group. Clinical outcomes, including length of hospital stay, did not differ between groups.

conclusionsIn this pilot study, there was significant in infants with gastroschisis that was partially attenuated by the administration of B longum subsp. infantis.

Indexed as

BifidobacteriumDouble-Blind MethodFecesFemaleGastroschisisHumansInfantLength of StayMalePilot ProjectsProbioticsTreatment Outcome

Identifiers

PMID26545203
PMCPMC4854817

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.